Skip to main contentSkip to navigation
Sirius Investors

HBMHF Stock: HBM Holdings Limited Stock Price, Analysis & Insights

Get live HBMHF stock price $1.56, comprehensive HBM Holdings Limited stock analysis, charts, news, and expert forecast. Real-time HBMHF stock data and investment insights.

1.56
0.00%Today
HBMHFHBM Holdings Limited • Other OTC • Healthcare
Market Cap
1.30B
Volume
100
52W High
2.54
52W Low
1.10

Loading chart data...

HBM Holdings Limited (HBMHF) Overview

HBM Holdings Limited (HBMHF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, HBMHF trades at $1.56 with a market capitalization of 1.30B . Over the past 52 weeks, HBMHF has traded between $1.10 and $2.54 , with the current price positioned at approximately 32% of this range . The stock currently trades at...

Key Takeaways

  • Operates in the Healthcare sector (Biotechnology)
  • Market cap: 1.30B
  • Current price: $1.56
  • 52-week range: $1.10 - $2.54
  • P/E ratio: 13.00

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

HBM Holdings Limited is a biopharmaceutical company in the clinical development phase, dedicated to the discovery and advancement of differentiated antibody therapeutics for immunological and oncological disorders. The firm's robust pipeline includes...

Company Information

CEO
Jingsong Wang
Sector
Healthcare
Industry
Biotechnology
Employees
183

Contact Information

Address
Tower A, 12th Floor
Country
CN

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 13.0)

Higher growth potential with elevated volatility (Beta: 1.35)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for HBM Holdings Limited shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for HBM Holdings Limited
  • Investors should consider how HBM Holdings Limited fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

1.30B

P/E Ratio (TTM)

13.00

Beta

1.35

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.